What Analysts Are Saying About Henry Schein Stock
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
Strategic Investment and Growth Potential Drive Buy Rating for Henry Schein Despite Underwhelming Guidance
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...
Henry Schein price target raised to $90 from $82 at Barrington
Barrington analyst Michael Petusky raised the firm’s price target on Henry Schein (HSIC) to $90 from $82 and keeps an Outperform rating on the ...
Mizuho raises Henry Schein stock target to $78, keeps neutral stance
Securities updated their financial outlook on Henry Schein (NASDAQ:HSIC), increasing the price target to $78 from the previous $75, while maintaining a Neutral rating on the company's stock. According ...